文献速递甲状腺疾病

甲状腺癌腺叶切除术后复发检测:甲状腺球蛋白与甲状腺球蛋白抗体的作用

Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究纳入167例因甲状腺乳头状癌行腺叶切除术并随访超过1年的患者,评估甲状腺球蛋白(Tg)和甲状腺球蛋白抗体(TgAb)对复发检测的价值。结果显示基础Tg及Tg动态变化均不能预测疾病复发,单独使用血清Tg对腺叶切除术后预测或检测复发的价值有限。

要点

  • 腺叶切除术后平均Tg为12.1 ± 14.8 ng/mL,合并桥本甲状腺炎者38% TgAb阳性。
  • 随访前2年42%患者Tg下降≥1 ng/mL,22%稳定,36%升高。
  • 基础Tg及Tg动态变化均不能预测疾病复发。

核心结论

  • 单独使用血清甲状腺球蛋白对甲状腺腺叶切除术后预测或检测疾病复发的价值有限。
  • Tg在检测腺叶切除术后远处转移等方面的其他潜在作用有待进一步研究。

研究设计与样本

  • 研究纳入因甲状腺乳头状癌行腺叶切除术并随访超过1年、具有足够Tg和TgAb数据的患者,共167例符合纳入标准。
  • 平均肿瘤大小为9.5 ± 6 mm。
  • 对合并桥本甲状腺炎及对侧结节的患者进行了亚组分析。

主要发现

  • 腺叶切除术后Tg为12.1 ± 14.8 ng/mL。
  • 52例桥本甲状腺炎患者中38% TgAb阳性,滴度为438 ± 528 IU/mL;TgAb阴性者平均Tg为14.7 ± 19.0 ng/mL。
  • 34例对侧结节≥1 cm的患者Tg为15.3 ± 17 ng/mL。
  • 随访前2年,42%患者Tg下降≥1 ng/mL(下降5.1 ± 3.7 ng/mL),22%保持稳定,36%升高(升高4.9 ± 5.7 ng/mL)。
  • 平均随访6.5年(78 ± 43.5个月)期间,18例患者行补充性甲状腺切除术,12例诊断为对侧癌(n=8)或淋巴结转移(n=4)。

临床怎么用

  • 原文结论认为单独使用血清甲状腺球蛋白对腺叶切除术后预测或检测疾病复发的价值有限,未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) for detecting disease recurrence is well validated following total thyroidectomy and radioiodine ablation. However, limited data are available for patients treated with thyroid lobectomy. METHODS: Patients who had lobectomy for papillary thyroid cancer followed for >1 year, with sufficient data on Tg and TgAb, including subgroup analysis for Hashimoto's thyroiditis and contralateral nodules. RESULTS: One-hundred sixty-seven patients met the inclusion criteria. Average tumor size was 9.5 ± 6 mm. Following lobectomy, Tg was 12.1 ± 14.8 ng/mL. Of 52 patients with Hashimoto's thyroiditis, 38% had positive TgAb with titers of 438 ± 528 IU/mL, and in patients without TgAb the mean Tg level was 14.7 ± 19.0 ng/mL. In 34 patients with contralateral nodules ≥1 cm, Tg was 15.3 ± 17 ng/mL. During the first 2 years of follow-up, Tg declined ≥1 ng/mL in 42% of patients (by 5.1 ± 3.7 ng/mL), remained stable in 22%, and increased in 36% (by 4.9 ± 5.7 ng/mL). During a mean follow-up of 6.5 years (78 ± 43.5 months), 18 patients had completion thyroidectomy and 12 were diagnosed with contralateral cancer (n = 8) or lymph node metastases (n = 4). In patients with recurrence followed for >2 years, there was a rise in Tg in 3 cases, Tg was stable in 2 cases, and in 1 TgAb decreased from 1534 to 276 IU/mL despite metastatic lymph nodes. Basal Tg and Tg dynamics did not predict disease recurrence. CONCLUSIONS: Serum thyroglobulin used independently is of limited value for predicting or detecting disease recurrence following thyroid lobectomy. Other potential roles of Tg, such as detecting distant metastases following lobectomy, should be further studied.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ritter A, Mizrachi A, Bachar G, et al. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies. J Clin Endocrinol Metab. 2020. PMID: 32219303. doi:10.1210/clinem/dgaa152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。